全文获取类型
收费全文 | 20156篇 |
免费 | 1419篇 |
国内免费 | 97篇 |
专业分类
耳鼻咽喉 | 186篇 |
儿科学 | 448篇 |
妇产科学 | 365篇 |
基础医学 | 2697篇 |
口腔科学 | 221篇 |
临床医学 | 1931篇 |
内科学 | 4554篇 |
皮肤病学 | 324篇 |
神经病学 | 2074篇 |
特种医学 | 946篇 |
外科学 | 3391篇 |
综合类 | 132篇 |
一般理论 | 6篇 |
预防医学 | 1257篇 |
眼科学 | 209篇 |
药学 | 1381篇 |
中国医学 | 23篇 |
肿瘤学 | 1527篇 |
出版年
2023年 | 122篇 |
2022年 | 142篇 |
2021年 | 528篇 |
2020年 | 275篇 |
2019年 | 506篇 |
2018年 | 602篇 |
2017年 | 435篇 |
2016年 | 418篇 |
2015年 | 535篇 |
2014年 | 827篇 |
2013年 | 988篇 |
2012年 | 1504篇 |
2011年 | 1541篇 |
2010年 | 904篇 |
2009年 | 835篇 |
2008年 | 1261篇 |
2007年 | 1237篇 |
2006年 | 1220篇 |
2005年 | 1101篇 |
2004年 | 1089篇 |
2003年 | 925篇 |
2002年 | 913篇 |
2001年 | 337篇 |
2000年 | 296篇 |
1999年 | 263篇 |
1998年 | 170篇 |
1997年 | 166篇 |
1996年 | 124篇 |
1995年 | 132篇 |
1994年 | 110篇 |
1993年 | 103篇 |
1992年 | 153篇 |
1991年 | 157篇 |
1990年 | 150篇 |
1989年 | 152篇 |
1988年 | 145篇 |
1987年 | 122篇 |
1986年 | 118篇 |
1985年 | 106篇 |
1984年 | 82篇 |
1983年 | 84篇 |
1982年 | 55篇 |
1979年 | 60篇 |
1978年 | 57篇 |
1975年 | 47篇 |
1974年 | 48篇 |
1972年 | 48篇 |
1971年 | 41篇 |
1970年 | 48篇 |
1969年 | 39篇 |
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
1.
2.
3.
4.
5.
IntroductionInterprofessional learning (IPL) is a vital aspect of training in radiation oncology professions, yet is rarely delivered to those professionals who work most closely together in clinical practice. Scenario-based learning using simulation facilities provides a unique opportunity to facilitate this learning and this project aimed to determine the impact and value of this initiative.MethodsSmall groups comprising post-graduate diploma pre-registration therapeutic radiographers, medical physics trainees and radiation oncology registrars were challenged with 4 plausible and challenging radiotherapy scenarios within an academic simulation centre. Pre- and post-event completion of the “Readiness for Interprofessional Learning Scale” measured impact and a Likert-style survey gathered feedback from participants.ResultsThe session increased participants' teamwork and collaboration skills as well as strengthening professional identities. Participants reported high levels of enjoyment related to collaborative working, communication and observing other professionals deploying their technical skills and specialist knowledge.ConclusionAlthough beneficial, simulated scenarios offering equal opportunities for engagement across the professions are challenging to plan and timetabling issues between the 3 groups present significant difficulties. The safe environment and unique opportunity for these groups to learn together was particularly well received and future oncology-specific simulated scenario sessions are planned with larger cohorts.Implications for practiceSimulated scenario training can be used to improve team working across the radiotherapy interprofessional team and may have wider use in other specialist interdisciplinary team development. 相似文献
6.
7.
8.
9.
José A. Lorente Pablo Cardinal-Fernández Diego Muñoz Fernando Frutos-Vivar Arnaud W. Thille Carlos Jaramillo Aida Ballén-Barragán José M. Rodríguez Oscar Peñuelas Guillermo Ortiz José Blanco Bruno Valle Pinheiro Nicolás Nin María del Carmen Marin Andrés Esteban Taylor B. Thompson 《Intensive care medicine》2015,41(11):1921-1930
10.
Thierry Patrice David Olivier Ludovic Bourre 《Journal of environmental pathology, toxicology and oncology》2006,25(1-2):467-485
Photodynamic therapy (PDT) is based on the selective light activation of an exogenously given drug to patients. PDT acts mainly on cell membranes either of neovascular endothelial cells or of cancer cells leading to cancer cell death. Six drugs are now marketed based on clinical assays in various indications, which showed a clear cost efficiency as compared to other classical procedures. PDT is easy to handle and can be performed in medical installations fitting the conditions of health care in developing countries. Its cost effectiveness could represent an appropriate solution to the increasing number of cancers of various origin. However despite all the clinical results now available, PDT development remains slow. The reasons for this situation include cost of development, intellectual property, and competition between pharmaceutical companies. 相似文献